YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

LabCorp to purchase Covance in $6.1B deal

Posted online
LabCorp will pay about $6.1 billion in cash and stock to buy Covance in a tie-up that aims to improve clinical trial research for pharmaceuticals.

Based in Burlington, N.C., LabCorp officials said the new company would improve patient recruitment for trials, make the research more efficient and deliver drug data faster, according to USA TOday.

LabCorp Chairman and CEO David King will lead the combined company.

Read more from USA Today.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences